Reclast: The Miracle Oral Bisphosphonate Alternative?
Osteoporosis Drugs by Vivian Goldschmidt, MA .

Reclast: The Miracle Oral Bisphosphonate Alternative?

Let’s face it. When news breaks of an osteoporosis drug discovery that increases bone strength and reduces fractures in the hip, spine, wrist, leg, and rib, the medical establishment listens… and prescribes.1

Add to this the convenience of a once-yearly 15 minute intravenous infusion, and it seems like an osteoporosis treatment dream come true.

The drug I’m referring to is Reclast (zoledronic acid), marketed as Aclasta outside of the U.S.

Reclast is a recently approved bisphosphonate manufactured by pharmaceutical giant Novartis, and is portrayed as the magic osteoporosis and osteopenia solution.

It was developed as an alternative to oral bisphosphonates, such as Fosamax (alendronate), Boniva (ibandronate), and Actonel (risedronate), which have a long list of undesirable side-effects.

Persistent gastric disorders such as heartburn, nausea, and flatulence are the most common, making it difficult to follow the oral drug regimen. In fact, studies confirm a dismal and suboptimal rate of compliance for bisphosphonates.2 Based on a survey conducted by the International Osteoporosis Foundation, “up to 60% of patients who take a once-weekly bisphosphonate and nearly 80% who take a once-daily bisphosphonate discontinue treatment within a year.”3 So – at least in the eyes of Big Pharma – an intravenous infusion is a logical alternative to pills.

The “Solution” Brings New Problems

Unfortunately, the “solution” to circumvent undesirable side effects with the purpose of increasing compliance, brings about new problems – and they are quite undesirable, to say the least. In other words, in exchange for the often persistent and ultimately dangerous digestive problems caused by oral bisphosphonates, patients could be subject to other nasty symptoms after a Reclast infusion. (If you haven’t yet, check out my blog post titled “Alert: Bisphosphonates Double the Risk of Esophageal Cancer”.)

Here is a partial list of the most common side effects of Reclast:

  • Fever
  • Muscle, joint, and bone pain
  • Flu-like symptoms
  • Headaches

The Devastation of Osteonecrosis of the Jaw

But none of the above compare to the most damaging negative consequence of Reclast: the dreaded and ultimately virtually incurable Osteonecrosis of the Jaw (ONJ). Also known as dead jaw, ONJ is characterized by the inability of the jaw to heal following dental trauma or surgery. The jawbone tissue becomes infected and eventually dies. It is a very painful condition, leading to exposed bone and disfigurement.

Unfortunately, the treatment of ONJ is most often an unsuccessful challenge. According to a study conducted by the Department of Oral and Maxillofacial Surgery at Sheba Medical Center in Israel, there is only an 18% chance that ONJ will completely heal and a 52% chance that it will only partially heal with long-term antibiotic therapy.4 And the researchers found “no association between ONJ and diabetes, steroid and antiangiogenic treatment, or underlying periodontal disease.” The author’s conclusion is that “solutions for decreasing morbidity and poor outcome of ONJ remain elusive.”

In all fairness, the majority of the reported ONJ cases involved the use of a larger dose of zoledronic acid for the treatment of various cancers. So the drug called Zometa, also by Novartis, seems to ranks first, with the most reported cases of ONJ. But some studies show numbers where intravenous osteoporosis treatment caught up with ONJ diagnosis for certain types of cancer therapies.

For example, in a review of 19 ONJ bisphosphonate-related cases, 11 patients were treated for breast cancer, four patients for multiple myeloma, and also four cases for osteoporosis.5 Study authors describe ONJ as a “rare, but morbid condition.” Indeed, its symptoms are quite catastrophic, and include:

  • Pain, swelling, and/or infection of the gums
  • Loosening of teeth
  • Poor healing of gums
  • Numbness or the feeling of heaviness in the jaw
  • Partial or complete loss of the jaw bone

Risk vs. Reward

In view of these awful drug side effects, when you are faced with decisions about your bone health, it is critical you take a step back and look at all your options. A magical once-yearly infusion might sound tempting, but let’s not lose sight of the “What Ifs”.

In the end, Reclast is much like other bisphosphonates. It alters normal bone metabolism and sacrifices long-term results for temporary benefits. And worse yet, it does so by stopping the production of osteoclasts necessary for future osteoblast production and bone remodeling. For a more whimsical look at how bones renew themselves, be sure to check out: “How Your Bones Renew Themselves: An Inside Look”.

In light of this, that’s why I always recommend natural solutions that build your bones in harmony with your body.

Don’t go one more day without rebuilding your bones: If you haven’t yet, get the free Natural Bone Building Handbook as my gift to you and discover how simple it is to increase your bone density without dangerous side-effects. Then for detailed guidance every step of the way, try the Save Our Bones Program to accelerate your bone growth.

Stay natural and drug-free!

References

1 Black D, Delmas, S, Eastell R et al for the HORIZON Pivotal Fracture Trial. Once-yearly Zoledronic Acid for treatment of postmenopausal osteoporosis. NEJM 2007; 356(18):1809-22.
2 Cramer JA et al. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporosis International 2007. Volume 18, Number 8, 1023-1031.
3 Navid D. The Adherence Gap: Why Osteoporosis Patients Don’t Continue With Treatment. International Osteoporosis Foundation April 2005.
4 Lazarovici TS et al. Bisphosphonate-related osteonecrosis of the jaws: a single center study of 101 patients. J Oral Maxillofac Surg. 2009 Apr; 67(4):850-5.
5 Gill SB, et al. Bisphosphonate-related osteonecrosis of the mandible and maxilla: clinical and imaging features. J Comput Assist Tomogr. 2009 May-Jun; 33(3): 449-54.

email

If you liked this article, click the "Like" button for Facebook:

save our bones program

How Does The Save Our Bones Program Treatment Reverse Osteoporosis Without Drugs In One Year Or Less?

Learn more about how the Save Our Bones Program treatment is guaranteed to reverse osteoporosis and osteopenia in one year or less ...

Join the Conversation.  Leave a Comment.

Vivian Goldschmidt, MA

Vivian Goldschmidt, MA, is dedicated to sharing her health secrets through her books and publications. Vivian’s philosophy is simple: Armed with the true knowledge, anyone can achieve optimal health – and it’s lot simpler than we’re made to believe. Her revelations on modern “disease” continue to gain worldwide recognition.

65 Comments

  • magalas girl
    November 13, 2012
  • Joyce
    October 11, 2012
    • Janet
      March 28, 2013
  • jack cohen
    February 14, 2012
  • AD
    August 18, 2011
  • Tillie Berger
    June 8, 2011
  • louise nelson
    May 23, 2011
  • denise watson
    March 31, 2011
  • ann
    March 15, 2011
  • Eglee
    March 14, 2011
  • George Gesch
    February 26, 2011
  • Karis Alderson
    February 24, 2011
  • ramona pino
    February 20, 2011
    • ramona pino
      February 20, 2011
  • Marion
    February 13, 2011
  • Starman
    February 12, 2011
  • Chloa Smith
    February 12, 2011
  • mina jamshidi
    February 9, 2011
  • Jan
    February 8, 2011
    • Vivian Goldschmidt, MA
      February 9, 2011
      • Sue W.
        February 13, 2011
        • Vivian Goldschmidt, MA
          February 15, 2011
  • Alice Richards
    February 8, 2011
    • Vivian Goldschmidt, MA
      February 15, 2011
  • eileen wrede
    February 8, 2011
    • Customer Support
      February 9, 2011
  • JEAN
    February 8, 2011
  • Gerri D.
    February 8, 2011
  • Teresa
    February 8, 2011
  • Nu Ly
    February 8, 2011
  • catherine smith
    February 7, 2011
  • Patricia Rhodes
    February 7, 2011
    • D Fellows
      April 23, 2011
    • D Fellows
      April 23, 2011
      • Amber Wilson
        May 17, 2011
        • Patricia Glover
          October 30, 2012
        • sandra
          March 23, 2012
    • Vivian Goldschmidt, MA
      February 8, 2011
  • Andrea Moore
    February 7, 2011
  • LESLIE
    February 7, 2011
  • gloria
    February 7, 2011
  • gloria
    February 7, 2011
  • Pari Ahour
    February 7, 2011
    • Margaret Kelley
      February 7, 2011
  • Shula
    February 7, 2011
  • Kristine Marquier-Varzal
    February 7, 2011
  • Michael
    February 7, 2011
  • joyce
    February 7, 2011
  • Diane Matyskiewicz
    February 7, 2011
    • Marlene
      February 8, 2011
      • Marlene
        February 8, 2011
    • Bev Eschmann
      February 8, 2011
  • Annemarie
    February 7, 2011
    • Vivian Goldschmidt, MA
      February 8, 2011
  • Allison
    February 7, 2011
  • Angela Wynne-Robinson
    February 7, 2011
  • Marcia
    February 7, 2011
  • Duann
    February 7, 2011
    • Kennetha Gaebler
      February 7, 2011
    • marianne
      February 7, 2011
  • Erlinda Siatron
    February 7, 2011
  • Trudy
    February 7, 2011
  • Elan Van Ness
    February 7, 2011
    • Marie
      February 7, 2011
      • Katherine
        February 8, 2011
Show More Comments

Join the Conversation. Leave a Comment.

The purpose of this comment section is to encourage you to interact with the rest of the Save Our Bones Community. Thank you so much for joining the conversation!




Click here if you'd like to add an avatar to all of your comments →